期刊文献+

医院获得性下呼吸道感染阴沟肠杆菌的耐药性分析

Antibiotic resistance of Enterobacter cloacae in nosocomial low respiratory tract infection
下载PDF
导出
摘要 目的了解医院获得性下呼吸道感染阴沟肠杆菌临床分离株耐药性与超广谱β-内酰胺酶的发生率.方法分析2001年3月~2003年5月126例医院获得性阴沟肠杆菌下呼吸道感染患者的分离菌,采用纸片扩散表型试验检测超广谱β-内酰胺酶(ESBLs).结果阴沟肠杆菌产ESBLs率为29.4%,呼吸内科、胸外科、神经科等重症监护室(ICU)分离的阴沟肠杆菌产ESBLs率为44%,明显高于普通病房分离的阴沟肠杆菌的产ESBLs率(7.8%,P<0.005).产ESBLs阴沟肠杆菌对氨苄青霉素、环丙沙星及头孢他啶等头孢菌素的耐药率分别为100%、92.1%和100%.除哌拉西林和亚胺培南外,产ESBLs阴沟肠杆菌对常用12种抗菌药物的耐药性明显高于不产ESBLs菌.亚胺培南对产ESBLs与不产ESBLs的阴沟肠杆菌的抗菌活性均较高.结论阴沟肠杆菌ESBLs的检出率为29.4%,各科ICU阴沟肠杆菌ESBLs检出率更高.临床可选亚胺培南进行治疗. Objective To investigate the prevalence of nosocomial low respiratory tract infection by Enterobacter cloacae and survey the resistance and occurrence of ESBLs-producing strains. Methods Total of 126 cases with hospital acquired low respiratory infection by Enterobacter cloacae were collected from March 2001 to May 2004. Bacterial identification was done by Microscan Walk Away-40. ESBLs were detected by standard plate. Results The occurrence of ESBLs-producing strains of Enterobacter cloacae was 29. 4% while in ICU was 44%. It was significantly higher in ICU than that in general wards (7.8%, P〈0. 005). The resistant rate of ESBLs-producing strains to ampicillin, Ciprofloxacin and ceftazidime were 100%, 92.10% and 100%, respectively. The resistant rate of ESBLs-producing strains against most antibiotics was significantly higher than that of non-ESBLs-producing strains. Imipenem showed strong antimicrobial activity to most isolates. Conclusion The detection rate of ESBLs-producing bacteria was 29.4%. Those were mainly isolated from ICU, and mostly susceptible to imipenem.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2005年第11期669-671,共3页 Chinese Journal of Antibiotics
关键词 阴沟肠杆菌 耐药性 超广谱Β-内酰胺酶 医院感染 Enterobacter cloacae Drug resistance Extended-spectrum β-lactamase Nosocomial infection
  • 相关文献

参考文献6

二级参考文献16

  • 1罗光荣,刘祖春.102株克雷白菌鉴定与植生克雷白菌检出[J].中华医学检验杂志,1994,17(6):362-364. 被引量:11
  • 2黎世能,王浴生,雷军.β-内酰胺酶介导的阴沟杆菌对β-内酰胺类抗生素耐药机制的研究[J].中国抗生素杂志,1996,21(2):121-123. 被引量:5
  • 3秦俊玲,韩呈武,王素兰,李春英,王路,林桂秋.10年临床感染细菌的病原学与常用抗生素的调查分析[J].中华医院感染学杂志,1996,6(4):243-245. 被引量:59
  • 4[1]National Committee for Clinical Laboratory Standard. Performance standards for antimicrobial susceptibility testing [ S].Twelvth informational supplement. 2002,22: 90
  • 5[2]Liu Z G, Tan C, Chen M, et al. Analysis of Enterobacter cloacae infections and antimicrobial susceptibility [J]. Chin J Nosocomial, 2000,10 (6): 472
  • 6[3]Lei D P, Xü Y C, Xie X L. Drug resistance of 109 clinical isolates of Enterobacter cloacae [ J ]. Shanghai J Med Lab Sci, 1999,14(3): 147
  • 7[4]Kang M. Resistant mechanisms of Enterobacter cloacae of βlactams [J]. FMS Microbiol, 1997,20(3) :21
  • 8[5]Zhang Y L, Li J T, Zhao M W. Studies on chacacteristics of AmpC-type beta-lactamases of Enterobactercloacae [J]. Chin J Antibiot ,2000,20(6) :428
  • 9[6]Weigel L M, Steward C D, Tenover F C. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceas [J]. AntimicrobAgents Chemother ,1998,42(10) :2661
  • 10[7]Linde H J, Notka F, Irtenkauf C, et al. Increase in MICs of ciprofloxacin in vivo in two closely related clinical isolates of Enterobacter cloacae [J ]. J Antimicrob Chemother, 2002,49(4) :625

共引文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部